Concentric Medical’s Merci Cerebral Clot Remover Set For February Panel
This article was originally published in The Gray Sheet
Executive Summary
Concentric Medical will present neurological function data for its Merci embolic retrieval system to FDA's Neurological Devices Advisory Panel Feb. 23
You may also be interested in...
Concentric Medical Merci
Embolism retrieval system achieved cerebral revascularization in 51% of patients in the 81-patient, Phase I MERCI trial (41/81). The success rate, based on immediate post-procedure angiography, is a more accurate figure than the previously reported 81% rate that was based on 27 patients monitored with CT 24 hours post-procedure, according to the company (1"The Gray Sheet" Jan. 5, 2004, p. 7)...
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.